Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.
Press releases published on August 7, 2025
ESCO Reports Third Quarter Fiscal 2025 Results
St. Louis, Aug. 07, 2025 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the third quarter ended June 30, 2025 (Q3 2025). On July 21, 2025, the Company announced that it had completed …
Microchip Technology Announces Financial Results for First Quarter of Fiscal Year 2026
For the quarter ended June 30, 2025 Net sales of $1.0755 billion, increased 10.8% sequentially and declined 13.4% from the year ago quarter. The midpoint of our updated guidance provided on May 29, 2025 was net sales of $1.0575 billion. On a GAAP basis: …
Microchip Technology Announces Quarterly Cash Dividend on Common Stock of 45.5 Cents Per Share
CHANDLER, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that its Board of Directors declared a quarterly cash …
Critical One Signs Definitive Agreement for Uranium Properties
TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Critical One Energy Inc. (formerly Madison Metals Inc.) (“Critical One” or the “Company”) (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF0) is pleased to announce that the Company’s uranium asset sale to Dark Star Minerals …
Alta Equipment Group Announces Second Quarter 2025 Financial Results
Second Quarter Financial Highlights: Total revenues decreased $6.9 million year over year to $481.2 million but increased $58.2 million sequentially versus the first quarter of 2025 Construction Equipment and Master Distribution revenues increased $10.0 …
First LLM with Infinite Context Attention is here, wiping out $1.2 billion RAG market value by allowing AI to live outside the Matrix
SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Silicon Valley startup, iFrame™ AI, has quietly secured a nearly $20 million deal with a leading cloud provider to launch the world’s first Large Attention Model with an infinite context window - a …
Autoscope Technologies Corporation Announces Financial Results and Dividend Declaration
MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Autoscope Technologies Corporation (OTCQX: AATC) today announced results for its quarter and six months ended June 30, 2025. Net income for the quarter ended June 30, 2025 was $0.14 per basic and diluted share …
CytomX Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update
- May 12, 2025 announcement of positive interim data from ongoing Phase 1 study of CX-2051 (EpCAM Antibody Drug Conjugate) in patients with advanced colorectal cancer (CRC) - - CX-2051 Phase 1 dose expansions on track for data update in Q1 2026. Phase 2 …
Citing Benefits of 232 Tariffs, Century Aluminum Announces Restart to Bring Mt. Holly SC Plant to Full Production, Increasing U.S. Aluminum Production by 10%
CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) has announced plans to restart over 50,000MT of idled production at its Mt. Holly, SC smelter. Century will invest approximately $50 million in the effort, create over 100 …
Applied Optoelectronics Reports Second Quarter 2025 Results
SUGAR LAND, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ: AAOI) (“AOI”), a leading provider of advanced optical and HFC networking products that power the internet, today announced financial results for its second quarter …
KLEEN HY-DRO-GEN INC., Announces Launch of World’s first Zero-Emissions Hydrogen Furnace
TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- KLEEN HY-DRO-GEN INC., ( the “Company”)a Canadian clean energy company, has officially announced the public launch of KLEENHEAT™ hydrogen furnace, the world’s first and only On-Demand, Zero-Emissions home heating …
Pattern Computer Granted Indian Patent for Novel Cancer Therapy Candidate PCI020302
REDMOND, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in pattern discovery, today announced that the Indian Patent Office has granted a new patent titled "Therapeutic Compositions and …
Biodesix Announces Second Quarter 2025 Results and Highlights
Q2 2025 Revenue of $20.0 million, an increase of 12% over Q2 2024; Q2 2025 gross profit margin of 80%, a 150-basis point improvement from Q2 2024; Reiterating FY2025 Total Revenue Guidance of $80-85 million; Conference Call and Webcast Today at 4:30 p.m. …
Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced that on August 4, 2025, Apyx granted a nonstatuatory stock option to purchase 100,000 shares of common stock to John …
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update
-- Recorded $128.9 Million in Fiscal 2025 Revenue, Meeting Full-Year Guidance; Maintains Commitment to Mid-Term Outlook -- -- Nine New Programs Signed with New Customers During Fiscal 2025, Reflecting Growth into Modalities Beyond the Company's Traditional …
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates
Presented updated data at ASCO showing consistency with prior data, including 10.3-month median PFS and 39% ORR in patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer Initiated Phase 3 ReDiscover-2 trial in Q2 Approximately $657 million in cash …
INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes
BOCA RATON, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its …
BioAtla Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
CAB-EpCAM x CAB-CD3 bispecific T-cell engager (TCE) (BA3182) Phase 1 dose-escalation study ongoing, currently dosing 1.2 mg cohort; Phase 1 data readout expected 2H 2025 Fast Track Designated Ozuriftamab vedotin (Oz-V; CAB-ROR2-ADC) Phase 2 study ongoing; …
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
BOTHELL, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today reported financial results …
Inuvo Posts 25% Growth in the Second Quarter 2025
LITTLE ROCK, Ark., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, today announced its financial results for the second quarter and six-month period ended June 30, 2025. …